ArticleMolecular therapy. Nucleic acids2020

Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.

Alessandra Affinito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.